Document is current
Any future updates will be listed below
-
Authors
Alladin, Ashna
Guillemin, Isabelle
Chuang, Chien-Chia
Chao, Jingdong
Krol, Marieke
Zikos, Efstathios
Martincova, Renata
Brookes, Ella https://orcid.org/0009-0001-9710-3799
-
Funding
Funding for this research was provided by:
Sanofi Pasteur (Sanofi Pasteur)
Regeneron Pharmaceuticals (Regeneron Pharmaceuticals)
- License Information
-
More Information
Article History
Received: 22 January 2025
Accepted: 28 October 2025
First Online: 6 December 2025
Declarations
:
: The research study received ethical approval from the Western Copernicus Group Independent Review Board (IRB). All aspects of the research adhered to the ethical principles outlined in the Declaration of Helsinki, titled “Ethical principles for medical research involving human subjects” (“World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects.”, 2001).
: Not applicable, as data are anonymized.
: AA, IG and MK are employees of IQVIA and may hold stock or stock options in the company. IQVIA provided consulting services to Sanofi and received consultation fees in connection with the development of this manuscript. CCC, RM, and EB are employees of Sanofi and may hold stock or stock options in the company. JC is an employee of Regeneron Pharmaceuticals Inc. and may hold stock or stock options in the company. EZ is an external contractor working for Sanofi via Barrington James.
